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Erv41p and Erv46p: New Components of COPII Vesicles Involved in
Transport between the ER and Golgi Complex
Stefan Otte,* William J. Belden,* Matthew Heidtman,* Jay Liu,* Ole N. Jensen, ‡ and Charles Barlowe*
*Department of Biochemistry, Dartmouth Medical School, Hanover, New Hampshire 03755; and ‡Department of Biochemistry
and Molecular Biology, University of Southern Denmark, Odense University, DK-5230 Odense M, Denmark

Abstract. Proteins contained on purified COPII vesicles were analyzed by matrix-assisted laser desorption
ionization mass spectrometry combined with database
searching. We identified four known vesicle proteins
(Erv14p, Bet1p, Emp24p, and Erv25p) and an additional nine species (Yip3p, Rer1p, Erp1p, Erp2p,
Erv29p, Yif1p, Erv41p, Erv46p, and Emp47p) that had
not been localized to ER vesicles. Using antibodies, we
demonstrate that these proteins are selectively and efficiently packaged into COPII vesicles. Three of the
newly identified vesicle proteins (Erv29p, Erv41p, and
Erv46p) represent uncharacterized integral membrane
proteins that are conserved across species. Erv41p and
Erv46p were further characterized. These proteins colocalized to ER and Golgi membranes and exist in a
detergent-soluble complex that was isolated by immu-

noprecipitation. Yeast strains lacking Erv41p and/or
Erv46p are viable but display cold sensitivity. The expression levels of Erv41p and Erv46p are interdependent such that Erv46p was reduced in an erv41⌬
strain, and Erv41p was not detected in an erv46⌬ strain.
When the erv41⌬ or ev46⌬ alleles were combined with
other mutations in the early secretory pathway, altered
growth phenotypes were observed in some of the double mutant strains. A cell-free assay that reproduces
transport between the ER and Golgi indicates that deletion of the Erv41p–Erv46p complex influences the
membrane fusion stage of transport.
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Introduction
Membrane-bound transport vesicles are central intermediates for intracellular trafficking of proteins and lipids. The
production of many types of transport vesicles depends on
coat protein complexes that form vesicles and select the
desired set of cargo (Schekman and Orci, 1996). Although
the importance of vesicle carriers has been appreciated,
the molecular mechanisms underlying distinct stages in
vesicle-mediated transport are not well understood. Several approaches have been used to identify and characterize this protein machinery, including the isolation and
characterization of specific vesicle carriers involved in synaptic transmission, endocytosis, exocytosis, and intraGolgi transport (for reviews see Söllner and Rothman,
1996; Arvan and Castle, 1998; Foletti et al., 1999; Smith
and Pearse, 1999). We have undertaken a comprehensive
analysis of ER-derived transport vesicles to elucidate the
molecular events associated with transport between the
ER and Golgi compartments.
Transport between these early compartments of the
secretory pathway is bidirectional and mediated by the

COPI and COPII coat complexes. In general, it is thought
that the COPII coat buds vesicles from the ER for anterograde transport, whereas the COPI coat is responsible for
retrograde transport of recycled proteins from Golgi and
pre-Golgi compartments back to the ER (Mellman and
Warren, 2000). Formation of COPII-coated vesicles may
be reproduced in a cell-free reaction with purified soluble
components (the Sar1p GTPase, the Sec23p complex, and
the Sec13p complex) and washed ER membranes (Salama
et al., 1993; Barlowe et al., 1994). A highly purified preparation of uncoated ER-derived vesicles can be obtained
through a scaled up version of the cell-free budding assay.
Examination of purified vesicles on protein-stained gels
reveals a characteristic set of polypeptides that are solubilized by detergents but not by an elevated pH treatment
(Barlowe et al., 1994; Rexach et al., 1994). Some of the
abundant ER vesicle (Erv)1 proteins have been characterized (Barlowe et al., 1994; Schimmöller et al., 1995; Belden
and Barlowe, 1996; Powers and Barlowe, 1998) and are
found to cycle between the ER and Golgi compartments
and function in the processes of vesicle formation and/or
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site-specific membrane fusion. In this report, we extend
our studies to identify additional Erv proteins contained
on ER-derived vesicles by mass spectrometry coupled to
database searching. Several new Erv proteins were identified and two of these, Erv41p and Erv46p, were characterized further. Erv41p and Erv46p exist in a complex that is
probably conserved across species and appears to influence the vesicle fusion stage of transport between the ER
and Golgi compartments.

Materials and Methods
Yeast Strains and Media
Strains used for this study are listed in Table I. Unless noted otherwise,
cultures were grown at 30⬚C in rich medium (YPD, 1% Bacto-yeast extract, 2% Bacto-peptone, 2% dextrose) or in minimal medium (YMD,
0.67% yeast nitrogen base without amino acids, 2% dextrose) containing
the appropriate amino acid supplements. Standard yeast (Sherman, 1991)
and cloning protocols (Ausubel et al., 1987) were used.

Plasmid Construction
Primer sequences are listed in Table II. The sequences of ERV41
(YML067c) and ERV46 (YAL042w) were obtained from the Saccharomyces Genome Database. To generate plasmid pRS424-ERV41, the
ERV41 sequence, and ⵑ300 bp of its flanking upstream and downstream,
sequences were cloned from genomic DNA prepared from strain RSY255
using primers YML067c-NotI and YML067c-BamHI. The product was ligated into the NotI and BamHI restriction sites of the pRS424 vector
(Christianson et al., 1992). ERV46 and its flanking regions of ⵑ300 bp
were amplified using primers YAL042w-NotI and YAL042w-BamHI and
inserted into the NotI and BamHI sites of the pRS426 vector (Christianson et al., 1992) to yield plasmid pRS426-ERV46. Correct amplification
and integration were verified by DNA sequencing.
For the overexpression of fusion proteins bearing NH2-terminal 6x histidine tags, fragments of ERV41, ERV46, and OCH1 were inserted into
the BamHI and HindIII restriction sites of the pQE-30 vector (QIAGEN)
to yield plasmids pQE-30-ERV41, pQE-30-ERV46, and pQE-30-OCH1,
respectively. Primers YML067c-pQE-F and YML067c-pQE-R for
ERV41, YAL042w-pQE-F and YAL042w-pQE-R for ERV46, and primers OCH1-pQE-F and OCH1-pQE-R for OCH1 were used to amplify
portions of these genes from genomic RSY255 DNA.

Strain Construction
ERV41 was targeted for disruption with the HIS3 gene (Baudin et al.,
1993). An erv41::HIS3 construct was amplified using primers YML067cKO-F and YML067c-KO-R and pHISKO as a template. The product contains the HIS3 gene flanked by 43-bp upstream of the ERV41 start codon
and 45-bp downstream of the ERV41 stop codon and was used to transform CBY453 cells. Several transformants showing histidine prototrophy
were screened by PCR using primers YML067c-NotI and HIS3. One
(CBY763) tested positive and was sporulated. Strains carrying erv46⌬,
rer1⌬, or erv29⌬ null alleles disrupted with a KAN marker were generated by a deletion project (Winzeler et al., 1999; Research Genetics) and
crossed several times through the FY833/FY834 background to yield an
isogenic set of spores.
Erv46p, Erv41p, and Erv29p were tagged at their NH2 termini by the
addition of three repeated influenza virus hemagglutinin (HA) epitopes
and put under control of the GAL1 promoter (Longtine et al., 1998): plasmid pFA6a-His3MX6-PGAL1-3HA and primers YAL042w-F4 and
YAL042w-R3 were used to amplify the construct targeted to the ERV46
locus. CBY453 cells were transformed with this product and selected for
histidine prototrophy. Several isolates were grown in YP with 2% galactose and 0.2% glucose and screened for expression of tagged protein by
Western blot of membrane fractions using an anti-HA antibody. Approximately 50% of transformants tested positive, and one (CBY767) was
sporulated to yield strains CBY770 and CBY771. ERV41 was targeted
with a PCR product obtained using plasmid pFA6a-TRP1-PGAL1-3HA
and primers YML067c-F4 and YML067c-R3. Transformants were selected for tryptophan prototrophy and screened for expression of HAtagged protein. One positive diploid strain (CBY782) was sporulated
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to obtain strains CBY783 and CBY784. Primers YGR284c-F4 and
YGR284c-R3 and plasmid pFA6a-His3MX6-PGAL1-3HA were used to
amplify the construct directed to the ERV29 locus. CBY453 cells were
transformed and selected for growth on minimal media lacking histidine.
Three transformants were screened by Western blot with the anti-HA antibody, and one tested positive (CBY950). Yif1p was tagged by the insertion of three HA epitopes at its COOH terminus (Longtine et al., 1998),
using primers MHF2 and MHR1 and plasmid pFA6a-3HA-His3MX6 as
template. FY834 cells were transformed with the PCR product and selected for histidine prototrophy. 7 out of 10 transformants expressed
tagged protein, and one was analyzed further (CBY801).

Genetic Analyses
To generate strains carrying multiple mutations, erv14⌬, erv41⌬, and
erv46⌬, strains were mated with other mutants. If possible, diploids were
selected using markers of the parent strains, otherwise, zygotes were
picked under the microscope. Diploid strains were sporulated, and asci
were dissected on YPD plates using a micromanipulator. Plates were incubated at room temperature, and germinated spores were scored for mating types, markers, and growth on YPD plates at 16⬚C, room temperature,
30⬚C, 36⬚C, and 38⬚C. In cases where several loci had been replaced by the
HIS3 gene, deletions were scored by PCR using YML067c-NotI and
the HIS3 internal primer for the detection of the erv41::HIS3 allele and
the ERV14 specific primer GP3 (Powers and Barlowe, 1998) and the internal HIS3 primer to detect the erv14::HIS3 deletion. In cases where one of
the parent strains had a genetic background different from FY833/FY834,
spores were backcrossed several times to obtain isogenic strains.

Antibodies and Immunoblotting
Polyclonal antibodies were raised against 6x histidine–tagged NH2-terminal fusion proteins of fragments of Erv41p (amino acid positions 75–274),
Erv46p (amino acid positions 80–296), and Och1p (amino acid positions
302–480) expressed from plasmids pQE-30-ERV41, pQE-30-ERV46, and
pQE-30-OCH1, respectively. All of the recombinant proteins localized to
the insoluble fraction of cells disrupted in a French Press. These fractions
were solubilized with 8 M urea, and the fusion proteins were purified on
Ni-NTA agarose (QIAGEN) as recommended by the manufacturer.
The recombinant proteins were used to immunize rabbits according to
standard procedures. For Western blotting, these antisera were diluted
1:1,000.
Antibodies directed against carboxypeptidase Y (CPY), Emp47p,
Erv14p, Erv25p, Kar2p, plasma membrane ATPase, Sec12p, Sec23p,
Sec61p (Powers and Barlowe, 1998), Bos1p (Cao and Barlowe, 2000),
Rer1p (Boehm et al., 1997), and Yip1p (Yang et al., 1998) were described
earlier. A monoclonal anti-HA antibody was obtained from Berkeley Antibody Co. Western blots were developed using the ECL method (Amersham Pharmacia Biotech). For densitometric analysis, films were scanned
and plotted using NIH Image 1.52.

Subcellular Fractionation
Membrane fractions were prepared by the bead-beat method in lysis
buffer (25 mM Hepes, pH 7.0, 50 mM potassium acetate, 2 mM EDTA, 1
mM PMSF). Pellets were resolved on 12.5% polyacrylamide gels. Microsomes (Wuestehube and Schekman, 1992) and semiintact cells (Baker
et al., 1988) were prepared as described. Sucrose gradient fractionation of
membrane organelles was performed according to Powers and Barlowe
(1998). To determine whether Erv41p and Erv46p are integral membrane
proteins, semiintact FY834 cells were suspended in buffer (20 mM Hepes,
pH 7.0, 150 mM potassium acetate, 2 mM EDTA), in buffer with 1% Triton X-100, or in 0.1 M sodium carbonate, pH 11.0, 2 mM EDTA, incubated on ice for 10 min and centrifuged at 60,000 rpm in a TLA100.3 rotor
(Beckman Coulter) for 12 min. Equivalent amounts of the total, supernatant, and pellet fractions were resolved on a 12.5% polyacrylamide gel.

In Vitro Vesicle Budding and Transport Assays
The synthesis of COPII vesicles was performed on a preparative scale by
incubating washed microsomes in the absence or presence of the proteins
Sar1p, Sec13–31p complex, and Sec23–24p complex as described previously (Barlowe et al., 1994; Belden and Barlowe, 1996). After collection of
fractions from nycodenz density gradients, peak fractions were diluted
fourfold with buffer 88 and centrifuged at 60,000 rpm for 25 min in a
TLA100.3 rotor (Beckman Coulter) to collect vesicles. The membrane pel-
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Results
Identification of ERV Proteins

Figure 1. Identification of Erv proteins. COPII-coated vesicles
were synthesized in vitro from ER membranes in the presence of
COPII proteins (⫹), were solubilized in sample buffer, and were
resolved on a 15% polyacrylamide gel. As a negative control, a
mock reaction without COPII proteins (⫺) was performed. Proteins were silver stained for this figure. For mass spectroscopy,
proteins were stained with colloidal blue, and individual bands
were excised.
lets were dissolved in 40 l of sample buffer, and solubilized proteins were
resolved on a 15% polyacrylamide gel (Novex). Gels were developed with
a colloidal blue staining kit (Novex), and polypeptide staining bands were
excised for analysis by mass spectrometry as described (Jensen et al.,
1999). Analytical scale budding reactions were performed as described
(Barlowe et al., 1994), and packaging efficiencies were determined by densitometry of scanned blots. Vesicle tethering and fusion assays following
35
S-labeled glyco-pro–␣ factor (gp-␣-F) were described by Cao et al.
(1998). The data plotted in these experiments are the average of duplicate
determinations, and the error bars represent the range. Pulse–chase experiments were performed according to Belden and Barlowe (1996).

A protocol to generate ER-derived vesicles in vitro from
washed microsomes and purified COPII components
(Barlowe et al., 1994) was scaled up to prepare sufficient
amounts of material to observe polypeptides on proteinstained polyacrylamide gels (Belden and Barlowe, 1996).
A set of polypeptides was observed (Fig. 1), and individual
bands were subjected to tryptic peptide mass mapping by
matrix-assisted laser desorption/ionization mass spectrometry followed by sequence database searching as described
(Shevchenko et al., 1996; Jensen et al., 1999). Several proteins were identified, some that had been previously described and others that had not been characterized. Importantly, three of these proteins (Erv14p, Emp24p, and
Erv25p) had been identified in our initial approaches using automated NH2-terminal sequencing (Belden and Barlowe, 1996; Powers and Barlowe, 1998). Therefore, the isolated ER-derived vesicles are comparable to previous
preparations, which suggests that this method should allow
for the identification of additional Erv proteins. The
SNARE protein Bet1p (Newman and Ferro-Novick, 1987)
was also identified in this preparation and had been previously detected on ER-derived vesicles by immunoblot
analysis and is required for transport between the ER and
Golgi (Newman et al., 1992; Cao and Barlowe, 2000).
Nine other polypeptides identified in this preparation
had not been localized to ER-derived vesicles before.
Yip3p, Rer1p, Erp1p, Erp2p, Yif1p, and Emp47p are conserved proteins that had been characterized and are
thought to operate in transport through the early secretory
pathway (Sato et al., 1995; Schröder et al., 1995; Andrulis
et al., 1998; Yang et al., 1998; Marzioch et al., 1999).
Erv29p, Erv41p, and Erv46p represent uncharacterized
proteins. Peptides derived from the Erv29p band correspond to the ORF YGR284c that encodes a nonessential
35-kD integral membrane protein terminating in the sequence KKKIY. According to its apparent molecular
weight on polyacrylamide gels, we have designated this
protein Erv29p. YML067c encodes an uncharacterized
protein that has recently been immunoisolated from an
early Golgi compartment (Cho et al., 2000). We have designated this protein Erv41p according to its molecular
weight. YAL042w encodes a protein of unknown function
that was named Fun9p (“function unknown”) (Coleman et
al., 1986; Diehl and Pringle, 1991) but not further characterized. We propose to name this protein Erv46p referring
to its localization and molecular weight.

Selective Packaging of Erv Proteins In Vitro

Microsomes were solubilized on ice with buffer 88 containing 2% Triton
X-100 and 1 mM PMSF for 5 min, followed by a centrifugation at 14,000 g
for 5 min. Portions (25 l) of the supernatant were mixed with 1 ml of IP
buffer (15 mM Tris/HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100), 25 l
of a 50% protein A–Sepharose slurry (Amersham Pharmacia Biotech),
and a saturating amount of anti-HA antibody and were incubated at 4⬚C
for 2 h. The precipitates were washed four times with cold IP buffer,
eluted from the beads by heating at 95⬚C in sample buffer, and resolved
on polyacrylamide gels.

Authentic Erv proteins should be selectively and efficiently packaged into ER-derived vesicles in the presence
of COPII proteins. To test specific packaging of the uncharacterized proteins, we first generated strains that contained epitope-tagged versions of these proteins. Strain
CBY801 expresses a COOH terminally HA-tagged version of Yif1p that fully complements for YIF1 function. Erv29p (CBY950), Erv41p (CBY782), and Erv46p
(CBY767) were modified to contain the 3HA epitope at
their NH2 termini and were placed under the control of
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Immunoprecipitation Experiments

Table I. Strain List
Strain

FY833
FY834
RSY255
RSY263
RSY265
RSY267
RSY277
RSY281
RSY309
RSY962
RSY976
CBY99
CBY263
CBY300
CBY356
CBY358
CBY453
CBY763
CBY767
CBY770
CBY771
CBY782
CBY783
CBY784
CBY794
CBY795
CBY796
CBY797
CBY798
CBY799
CBY801
CBY822
CBY823
CBY825
CBY826
CBY829
CBY831
CBY832
CBY836
CBY840
CBY841
CBY842
CBY843
CBY844
CBY845
CBY847
CBY848
CBY849
CBY850
CBY851
CBY852
CBY853
CBY854
CBY855
CBY856
CBY857
CBY859
CBY860
CBY861
CBY862
CBY863
CBY877
CBY878
CBY884
CBY885

Genotype

Reference

MATa his3200 ura3-52 leu21 lys2202 trp163
MAT␣ his3200 ura3-52 leu21 lys2202 trp163
MAT␣ ura3-52 leu2-3,-112
MAT␣ sec12-4 ura3-52 leu2-3,112
MAT␣ sec13-1 ura3-52 his4-619
MAT␣ sec16-2 ura3-52 his4-619
MAT␣ sec21-1 ura3-52
MAT␣ sec23-1 ura3-52 his4-619
MAT␣ sec12-1 leu2-3,112
MATa sec35-1 lys2-801
MATa ura3-52 ypt1-3
FY834 with emp24::LEU2
MAT␣ trp1-1 ade2-1 ura3-1 leu2-3,112 can1-100 sed5-1
FY834 with uso1-1
FY834 with erv14::HIS3
FY833 with erv14::HIS3
FY833 x FY834
CBY453 diploid with ERV41/erv41::HIS3
CBY453 diploid with ERV46/ERV46::HIS3MX6-PGAL1-3HA
FY834 with ERV46::HIS3MX6-PGAL1-3HA
FY833 with ERV46::HIS3MX6-PGAL1-3HA
CBY453 diploid with ERV41/ERV41::TRP1-PGAL1-3HA
FY834 with ERV41::TRP1-PGAL1-3HA
FY833 with ERV41::TRP1-PGAL1-3HA
FY833 with erv41::HIS3 erv46::KAN
FY834 with erv41::HIS3 erv46::KAN
FY833 with erv41::HIS3
FY834 with erv41::HIS3
FY833 with erv46::KAN
FY834 with erv46::KAN
FY834 with YIF1::HIS3MX6-3HA
FY833 with erv14::HIS3 erv46::KAN
FY834 with erv14::HIS3 erv46::KAN
FY834 with erv14::HIS3 erv41::HIS3
FY833 with erv14::HIS3 erv41::HIS3
FY834 with ypt1-3
FY833 with emp24::LEU2 erv41::HIS3 erv46::KAN
FY834 with emp24::LEU2 erv41::HIS3 erv46::KAN
CBY822 containing pRS426-ERV46
FY833 with erv41::HIS3 ypt1-3
FY834 with erv41::HIS3 ypt1-3
FY833 with erv46::KAN ypt1-3
FY834 with erv46::KAN ypt1-3
FY833 with erv41::HIS3 erv46::KAN ypt1-3
FY834 with erv41::HIS3 erv46::KAN ypt1-3
CBY826 containing pRS424-ERV41
FY833 with erv41::HIS3 sec21-1
FY834 with erv41::HIS3 sec21-1
FY833 with erv46::KAN sec21-1
FY834 with erv46::KAN sec21-1
FY834 with erv41::HIS3 erv46::KAN sec21-1
FY833 with erv41::HIS3 sed5-1
FY833 with ade2-1 erv46::KAN sed5-1
FY834 with erv46::KAN sed5-1
FY833 with erv41::HIS3 erv46::KAN sed5-1
FY834 with ade2-1 erv41::HIS3 erv46::KAN sed5-1
FY833 with erv41::HIS3 sec12-1
FY834 with erv41::HIS3 sec12-1
FY833 with erv46::KAN sec12-1
FY834 with erv46::KAN sec12-1
FY833 with erv41::HIS3 erv46::KAN sec12-1
FY833 with erv14::HIS3 rer1::KAN
FY834 with erv14::HIS3 rer1::KAN
FY833 with erv41::HIS3 nce102::KAN
FY834 with erv41::HIS3 nce102::KAN

Winston et al. (1995)
Winston et al. (1995)
Kaiser and Schekman (1990)
Kaiser and Schekman (1990)
Kaiser and Schekman (1990)
Kaiser and Schekman (1990)
Kaiser and Schekman (1990)
Kaiser and Schekman (1990)
Kaiser and Schekman (1990)
Wuestehube et al. (1996)
Wuestehube et al. (1996)
Belden and Barlowe (1996)
Cao et al. (1998)
Barlowe (1997)
Powers and Barlowe (1998)
Powers and Barlowe (1998)
Powers and Barlowe (1998)
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
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Table I. continued
Strain

CBY893
CBY894
CBY909
CBY910
CBY911
CBY912
CBY913
CBY914
CBY915
CBY916
CBY917
CBY918
CBY919
CBY920
CBY921
CBY922
CBY923
CBY924
CBY930
CBY931
CBY932
CBY933
CBY934
CBY940
CBY941
CBY942
CBY943
CBY944
CBY945
CBY948
CBY949
CBY950
CBY963
CBY964
CBY965
CBY966
CBY967
CBY968
CBY969
CBY970

Genotype

FY833 with erv14::HIS3 erv41::HIS3 erv46::KAN
FY834 with erv14::HIS3 erv41::HIS3 erv46::KAN
FY833 with erv46::KAN uso1-1
FY834 with erv46::KAN uso1-1
FY833 with erv41::HIS3 uso1-1
FY834 with erv41::HIS3 uso1-1
FY833 with erv41::HIS3 erv46::HIS3 uso1-1
FY834 with erv41::HIS3 erv46::HIS3 uso1-1
FY833 with erv46::KAN sec23-1
FY834 with erv46::KAN sec23-1
FY833 with erv41::HIS3 sec23-1
FY833 with erv41::HIS3 erv46::KAN sec23-1
FY834 with erv41::HIS3 erv46::KAN sec23-1
FY833 with erv46::KAN sec16-2
FY834 with erv46::KAN sec16-2
FY833 with erv41::HIS3 sec16-2
FY834 with erv41::HIS3 sec16-2
FY834 with erv41::HIS3 erv46::KAN sec16-2
FY834 with erv41::HIS3 erv46::KAN sec13-1
FY833 with erv41::HIS3 erv46::KAN sec13-1
FY834 with erv41::HIS3 sec13-1
FY834 with erv46::KAN sec13-1
FY833 with erv46::KAN sec13-1
FY833 with erv46::KAN sec35-1
FY834 with erv46::KAN sec35-1
FY833 with erv41::HIS3 sec35-1
FY834 with erv41::HIS3 sec35-1
FY833 with erv41::HIS3 erv46::KAN sec35-1
FY834 with erv41::HIS3 erv46::KAN sec35-1
FY833 with erv41::HIS3 rer1::KAN
FY834 with erv41::HIS3 rer1::KAN
CBY453 diploid with ERV29/ERV29::HIS3MX6-PGAL1-3HA
FY833 with erv14::HIS3 rer1::KAN
FY834 with erv14::HIS3 rer1::KAN
FY833 with erv29::KAN
FY834 with erv29::KAN
FY833 with erv29::KAN erv41::HIS3
FY834 with erv29::KAN erv41::HIS3
FY833 with erv14::HIS3 erv29::KAN
FY834 with erv14::HIS3 erv29::KAN

the GAL1 promoter (Longtine et al., 1998). Galactose induction resulted in stable expression of these tagged proteins and localization to ER membranes. However, we
cannot assess if these proteins are fully functional because
ERV29, ERV41, and ERV46 are not essential. In vitro
budding experiments were performed with microsomes
from these strains (Fig. 2 A), and the relative packaging
efficiencies were determined by comparing the lanes that
represent 10% of the complete reactions (T) with the
lanes that contain vesicles synthesized in the presence of
COPII (⫹). Yif1p-3HA (8%), 3HA-Erv29p (13%), 3HAErv46p (10%), and 3HA-Erv41p (13%) were incorporated into vesicles at levels comparable to the positive controls Erv25p (14% for CBY801 and 5% for CBY950) and
the v-SNARE Bos1p (11 for CBY767 and 5% for
CBY782), whereas the ER resident proteins Sec12p and
Sec61p were excluded. These results indicate that Yif1p,
Erv29p, Erv41p, and Erv46p are selectively packaged into
COPII vesicles.
Next, we prepared or obtained specific polyclonal antibodies against several of the newly identified Erv proteins
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to measure their packaging efficiencies when endogenously
expressed. As seen in Fig. 2 B, vesicles budded from wildtype microsomes contained Erv41p and Erv46p at levels
(20% and 26%, respectively) that are higher than those of
HA-tagged versions. Yip1p was packaged very efficiently
(65%), as was Rer1p (51%; Sato et al., 1995). The early
Golgi marker Och1p (Nakayama et al., 1992) was packaged
to a significantly lesser extent (8%). The positive controls
Erv14p, Erv25p, and Bos1p were efficiently packaged,
whereas the ER marker proteins Sec12p, Sec61p, and
Kar2p were excluded. Thus, Erv29p, Erv41p, Erv46p,
Yif1p, Yip1p, and Rer1p meet the initial requirement of
Erv proteins as they are selectively exported from ER
membranes under reconstituted vesicle budding conditions.

Molecular Characterization of Erv41p and Erv46p
For the remainder of this report, we investigate the
Erv41p and Erv46p proteins and their potential role in
transport through the early secretory pathway. Erv29p will
be described elsewhere. Erv41p is encoded by the ORF
YML067c on chromosome XIII, and conceptual transla-
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Table II. Primer Sequences
Primer

YML067c-NotI
YML067c-BamHI
YAL042w-NotI
YAL042w-BamHI
YML067c-pQE-F
YML067c-pQE-R
YAL042w-pQE-F
YAL042w-pQE-R
OCH1-pQE-F
OCH1-pQE-R
YML067c-KO-F
YML067c-KO-R
HIS3
YAL042w-F4
YAL042w-R3
YML067c-F4
YML067c-R3
YGR284c-F4
YGR284c-R3
MHF2
MHR1

Sequence

5⬘-ATAAGAATGCGGCCGCAACTCCCCTTCTCCAGACTTG-3⬘
5⬘-CGCGGATCCGCGAAGTATGCGGGACGCTG-3⬘
5⬘-ATAAGAATGCGGCCGCCTGCAGATGACATTGCGCTGC-3⬘
5⬘-CGCGGATCCGCCATGATCTCTCGGGTTGG-3⬘
5⬘-CGCGGATCCACGAAATGTGATTGGTTGC-3⬘
5⬘-CCCAAGCTTCACCTTTAGCAGCGACATC-3⬘
5⬘-CGCGGATCCTGTGACCTGGTGAATCTCG-3⬘
5⬘-CCCAAGCTTCCTGTCCGGGAACACC-3⬘
5⬘-CGCGGATCCGATCCAAGATTTGAAGAAG-3⬘
5⬘-CCCAAGCTTGGGTATGATGAAAGGAGAG-3⬘
5⬘-TGCTTTTGCTGTAACGTACAGGCAGAGACTTCAGGAGTATATAGGCCTCCTCTAGTACACTC-3⬘
5⬘-GAAACGTTATCTTGGGTATACTGCATTCTCTTTTCTTTTACATATGCGCGCCTCGTTCAGAATG-3⬘
5⬘-GCCTCATCCAAAGGCGC-3⬘
5⬘-CGCCATTATAAAGGAAAGCTAGTTTTATGTCTCGTATACAGAATTCGAGCTCGTTTAAAC-3⬘
5⬘-TAGCGAATGCGTCCAGCGACAGCAACGTGGACCTTTTCATGCACTGAGCAGCGTAATCTG-3⬘
5⬘-GATATTATCAATGTTCTATTCTTACTGAGAAAAGCGTTCCGAATTCGAGCTCGTTTAAAC-3⬘
5⬘-ATAACATACGAAACGCATCAAATGTCTTCAATCCTGCCATGCACTGAGCAGCGTAATCTG-3⬘
5⬘-ACGAAAGATCAAAGGTGTCCTTATTTACTTACAATAGCTGGAATTCGAGCTCGTTTAAAC-3⬘
5⬘-GGCATACCGCCAAAATTTCCAATAGGTCCTCTGTAAGACATGCACTGAGCAGCGTAATCTG-3⬘
5⬘-TGGCTTCATTTGGCAAAATGTTCTAATGTGGTTAATGGGTCGGATCCCCGGGTTAATTAA-3⬘
5⬘-GCATGAAATTAAATCCTCTCTTTGATCTCTTCAATCAAGAGAATTCGAGCTCGTTTAAAC-3⬘

tion yields a protein of 352–amino acid residues and a predicted molecular weight of 40.6 kD. The ORF YAL042w
on chromosome I encodes Erv46p, a protein predicted to
be composed of 415–amino acid residues with a molecular
weight of 46 kD. Database alignments showed that Erv41p
and Erv46p exhibit significant sequence similarity. Both
proteins also have one putative homologue each in Caenorhabditis elegans, Drosophila melanogaster, and humans, however, no known functions have been reported
for these proteins. Sequence identity scores (Table III) between Erv41p and its homologues (CDA14, EG:65F1.1
and C18B12.6) are higher than those between Erv41p and
Erv46p. Similarly, Erv46p and its homologues in other
species (the 43.2-kD protein, CG70, and K09E9.2) show
even higher identity scores. The Erv46p group is further
characterized by eight conserved cysteine residues in their
NH2-terminal half. Erv46p also terminates in the COPI
binding motif KKXX (Jackson et al., 1990; Cosson and Letourneur, 1994), a feature that is conserved across species.
These results suggest that a conserved set of Erv41p–
Erv46p proteins are found in other species and are likely
to perform a similar function.
ERV41 as well as ERV46 were amplified from genomic
DNA and inserted into the multicopy shuttle vectors
pRS424 and pRS426, respectively, to yield plasmids
pRS424-ERV41 and pRS426-ERV46. Polyclonal antisera
were raised against recombinant forms of Erv41p and
Erv46p and then tested on wild-type, deletion, and over-

Figure 2. Selective packaging of Erv proteins into COPII-coated
vesicles in vitro. (A) In vitro budding reactions with microsomes
prepared from strains expressing tagged versions of Erv proteins:
Yif1p-3HA (CBY801), 3HA-Erv29p (CBY950), 3HA-Erv46p
(CBY767), and 3HA-Erv41p (CBY782). One tenth of a total reaction (T), budded vesicles isolated after incubation with COPII
proteins (⫹), or a mock reaction without COPII proteins (–)
were separated on a 12.5% polyacrylamide gel. Tagged proteins
were visualized by immunoblot with an anti-HA antibody, and

Sec61p or Sec12p (ER resident proteins) as negative controls and
Erv25p (Erv protein) or Bos1p (v-SNARE) as positive controls
were detected using polyclonal antisera. (B) In vitro budding reactions with FY834 wild-type microsomes. The same budding
protocol as in A was used. Proteins were detected with polyclonal
antisera against Sec12p, Kar2p, and Sec61p (ER residents),
Bos1p (v-SNARE), Och1p (early Golgi marker), and the Erv
proteins Erv46p, Erv41p, Erv25p, Erv14p, Rer1p, and Yip1p.
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Table III. Percent Sequence Identities between Erv46p, Erv41p, and Their Homologues

Erv46p (S. cerevisiae)
Erv41p (S. cerevisiae)
K09E9.2 (C. elegans)
C18B12.6 (C. elegans)
CG7011 (D. melanogaster)
EG:65F1.1 (D. melanogaster)
43.2 kD protein (H. sapiens)

Erv46p

Erv41p

K09E9.2

C18B12.6

CG7011

EG:65F1.1

43.2 kD

CDA14

100

28
100

38
32
100

12
25
20
100

38
28
41
20
100

27
32
27
20
27
100

41
31
43
17
47
31
100

25
30
32
21
34
35
38
100

CDA14 (H. sapiens)

Full-length sequences were aligned using the CLUSTAL V algorithm of GeneInspector v1.5 with the BLOSUM62 table and default settings (k-tuple 1, maximum gap length 5,
gap penalty 3, 5 top diagonals).

producing strains to confirm their specificity (Fig. 3). No
immunoreactive species were detected in the deletion
strains, whereas the heterozygous diploid strains carrying
one wild-type and one tagged copy of the respective genes
expressed two immunoreactive species at the expected
size. This result also demonstrated that expression levels
from the GAL1 promoter were comparable to wild-type
expression levels at a concentration of 1.5% galactose.
Strains harboring ERV41 or ERV46 on 2 based multicopy plasmids expressed slightly higher levels of Erv41p or
Erv46p than wild-type strains.
Both Erv41p and Erv46p contain two segments of sufficient length and hydrophobicity to form transmembrane domains, and the short NH2- and COOH-terminal regions of
both proteins are predicted to be located on the cytoplasmic
side with a large lumenal domain separating the two transmembrane regions. The hydrophilicity plots of both proteins
are superimposable (Fig. 4 A), and a similar topology is predicted for all of the known homologues. There is no evidence for a cleavable signal sequence. To confirm that
Erv41p and Erv46p are indeed integral membrane proteins,
we examined their fractionation behavior under conditions
that release lumenal and peripherally bound membrane proteins (carbonate buffer, pH 11.0) or solubilize integral membrane proteins (1% Triton X-100). The fractionation profile
for Erv41p and Erv46p was the same as for the integral
membrane protein Bos1p, as they could only be solubilized
by detergent and not by carbonate treatment (Fig. 4 B).

The abundant Erv proteins are hypothesized to cycle
between the ER and Golgi (Belden and Barlowe, 1996;
Powers and Barlowe, 1998) because they localize to both
of these membrane compartments, and, in contrast to
abundant secretory proteins, their levels are not diminished by cycloheximide treatment (Yeung et al., 1995).
Therefore, we examined the subcellular localization of
Erv41p and Erv46p by resolution of membrane organelles on sucrose gradients (Fig. 5). Erv41p and
Erv46p sedimented in two peaks, one that coincided
with the Golgi marker Emp47p and the other with the
ER marker Kar2p. This subcellular localization pattern
was similar to that of Erv14p (Powers and Barlowe,
1998) and Erv25p (Belden and Barlowe, 1996). Rer1p
has been shown to be predominantly localized to the
Golgi (Sato et al., 1995) and to recycle between the
Golgi and ER (Boehm et al., 1997). Consequently, we
find that the majority of Rer1p cosedimented with
Emp47p, and a second smaller peak cosedimented with
Kar2p. In contrast, Och1p was localized almost exclusively to the Golgi. The localization of the epitopetagged Erv46p was also examined by indirect immunofluorescence using the anti-HA antibody (data not
shown). We observed a perinuclear staining pattern that
partially overlapped with the ER marker Kar2p and was
similar to that described for Erv14p (Powers and Barlowe, 1998). We conclude that Erv41p and Erv46p localize to the early secretory pathway.

Figure 3. Immunoblot analysis of wild-type, erv41⌬, and
erv46⌬ deletion and overproducing strains. FY834
wild-type (wt), erv46⌬ (46⌬,
CBY799), and erv41⌬ (41⌬,
CBY797) strains were grown
in YPD medium. Heterozygous diploid strains expressing NH2 terminally 3HAtagged Erv46p (46/HA46,
CBY767) or Erv41p (41/
HA41, CBY782) were grown
in YP with 1.5% galactose
and 0.5% glucose. erv14⌬
erv46⌬ deletion strains carrying pRS426-ERV46 plasmid (2 46, CBY836) or pRS424-ERV41 plasmid (2 41, CBY847) were grown in minimal media lacking
uracil or tryptophan, respectively. Membrane fractions were resolved on a 12.5% polyacrylamide gel and immunoblotted with an antiKar2p antiserum as loading control and with polyclonal antisera raised against Erv46p or Erv41p.
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Figure 4. Erv46p and Erv41p are integral membrane proteins.
(A) Hydrophilicity plots according to Kyte and Doolittle (1982)
with a window size of 7. The schematic representations of the
polypeptide chains indicate the positions of the putative transmembrane domains (TM1 and TM2) predicted by the HMMTOP
program (Tusnady and Simon, 1998), the region containing conserved cysteine residues (Cys) and the KKXX motif (black dot).
(B) Semiintact FY834 cells were treated with buffer (Materials
and Methods), buffer containing 1% Triton X-100 (TX100), or
0.1 M Na2CO3 (pH 11) and centrifuged at 100,000 g. Totals before centrifugation (T), supernatant (S), and pellet (P) fractions
were analyzed on a 12.5% polyacrylamide gel and immunoblotted for Sec23p (peripheral membrane protein), Erv46p, Erv41p,
and Bos1p (integral membrane protein).

Analysis of the erv41∆ and erv46∆ Strains
To investigate the function of Erv41p and Erv46p, we analyzed strains bearing null alleles at the ERV41 or ERV46
loci. A PCR-based approach was used to direct the HIS3
gene to the ERV41 locus, replacing the entire ERV41 ORF.
A heterozygous ERV41/erv41⌬ diploid strain (CBY763)
was sporulated, and dissection of asci produced four viable
spores. Tetrad analysis of these spores for the HIS3 marker
confirmed that ERV41 was not essential for vegetative
growth, although spores carrying the deletion were slightly
delayed in their germination (data not shown). A haploid
strain in which the ERV46 reading frame had been replaced
by a KAN marker (Winzeler et al., 1999) was crossed three
times through the FY833/FY834 background to obtain the
isogenic haploid erv46⌬ strains CBY798 and CBY799.

The haploid erv41⌬ strains (CBY796 and CBY797)
grew at rates comparable to wild-type strains at 30⬚C and
37⬚C but displayed a reduced growth rate at 16⬚C (Fig. 6
B). The cellular morphology as determined by light mi-
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Figure 5. Sucrose gradient fractionation of Erv41p, Erv46p, Och1p,
and Rer1p. An FY834 whole cell lysate was separated on an 18–
60% sucrose density gradient, and fractions were collected, starting
with fraction 1 at the top. (A) Relative levels of Emp47p (Golgi
marker), Kar2p (ER marker), and plasma membrane marker
(PMA) in each fraction were quantified by densitometry of immunoblots. (B) Relative levels of Och1p, Erv46p, Erv41p, and Rer1p as
determined by densitometry of the immunoblots shown in C.

tered in an erv41⌬ strain and the major secretory proteins
contained in culture supernatants were also unchanged
(data not shown). Therefore, deletion of ERV41 does not
appear to interfere with general secretion. We performed
a similar set of analyses on erv46⌬ strains and observed
phenotypes that were identical to erv41⌬ strains, notably a
reduced growth rate at 16⬚C. Furthermore, erv41⌬ erv46⌬
strains did not exhibit any exacerbated phenotypes compared with the single deletions strains (Fig. 6 B).
Next, we investigated possible influences of the erv41⌬
and erv46⌬ deletions on other mutations that impede
transport through the early secretory pathway (Table IV
and Fig. 6). First, we examined phenotypes combined with
null alleles of other known ERV genes. An erv14⌬ strain
(CBY356) also exhibits a delayed rate of spore germination, a slightly slower growth rate in YPD at 30⬚C (increase in doubling time of ⵑ18% over the wild type), and
cold sensitivity. These phenotypes are significantly exacerbated by either erv41⌬ or erv46⌬. In erv14⌬ erv41⌬
(CBY825) and erv14⌬ erv46⌬ (CBY823) strains, germination is delayed by several days (Fig. 6 A), the doubling
time is increased by ⵑ40% compared with the wild type,
and cold sensitivity is increased. The triple erv14⌬ erv41⌬
erv46⌬ (CBY894) mutant does not show any further exacerbation of these phenotypes except that its germination is
extremely delayed by ⵑ1 wk at room temperature. In contrast to the erv14⌬ effects, combining emp24⌬ with erv41⌬
or erv46⌬ did not alter growth phenotypes.
Also, we investigated the influences of erv41⌬ and
erv46⌬ deletions on thermosensitive mutations in known
budding, tethering, and fusion genes. An erv41⌬ ypt1-3
strain (CBY841) showed a significantly decreased thermosensitivity compared with ypt1-3 alone (CBY829). The
same effect was observed in a ypt1-3 erv41⌬ erv46⌬ strain
(CBY845), whereas erv46⌬ alone slightly exacerbated the
thermosensitivity of ypt1-3 (CBY843, Fig. 6 C). In contrast, no effect was observed with the other tethering mutations uso1-1 and sec35-1. The erv41⌬ or erv46⌬ null mutations did not influence any of the growth phenotypes
associated with mutations in the COPI (sec21-1), COPII
(sec12-4, sec13-1, sec16-1, and sec23-1), or fusion (sed5-1)
proteins. Finally, we did not observe any synthetic effects
when the erv41⌬ or erv46⌬ mutations were combined with
rer1⌬ or erv29⌬.
Figure 6. Genetic experiments with erv41⌬ and erv46⌬ strains. (A)
An erv14⌬ strain (CBY358) was mated with an erv46⌬ strain
(CBY799), and spores were dissected on a YPD plate. Spores that
germinated and grew slower were shown to carry both deletions. (B)
Cold sensitivity of erv14⌬, erv41⌬, and erv46⌬ strains. Wild-type
(FY834), erv46⌬ (CBY799), erv41⌬ (CBY797), erv14⌬ (CBY356),
erv14⌬ erv46⌬ (CBY823), erv14⌬ erv41⌬ (CBY825), erv41⌬
erv46⌬ (CBY795), and erv14⌬ erv41⌬ erv46⌬ (CBY894) strains
were grown to saturation in YPD, adjusted to an OD600 of 3.0, and 5
l of a 10-fold dilution series were spotted onto YPD plates. (C) Effects of erv41⌬ and erv46⌬ mutations on the ypt1-3 mutation. Wildtype (FY834), ypt1-3 (CBY829), erv46⌬ ypt1-3 (CBY843), erv41⌬
ypt1-3 (CBY841), erv41⌬ erv46⌬ ypt1-3 (CBY845), and erv41⌬
erv46⌬ (CBY795) cells were spotted on YPD plates as in B.

Effects of erv41∆ and erv46∆ on Transport to the Golgi

croscopy as well as the mating and sporulation efficiencies
of an erv41⌬ strain were indistinguishable from the
isogenic wild-type strains. Intracellular transport of the
secretory proteins CPY and Gas1p was not detectably al-

Since erv41⌬ and erv46⌬ strains did not exhibit major defects in secretion, but the erv14⌬ erv46⌬ strains showed an
exacerbated growth phenotype, we examined the transport
kinetics in this strain compared with wild-type and the single erv14⌬ and erv46⌬ strains. A pulse–chase experiment
was performed in which cells were grown in minimal media
and pulsed for 7 min with [35S]methionine and [35S]cysteine
to label newly synthesized proteins. Excess unlabeled cysteine and methionine were added for the chase phase, and
the maturation of CPY was followed by immunoprecipitation with an anti-CPY antibody. CPY first appears in the
ER as the P1 precursor form of 67 kD and is then modified
in the Golgi to yield its P2 form of 69 kD and finally processed in the vacuole to the mature M form of 61 kD
(Stevens et al., 1984). As seen in Fig. 7, a slight delay in
transport of CPY was observed in an erv14⌬ strain (Powers and Barlowe, 1998), and, when combined with erv46⌬,
no further decrease in the transport rate was detected.
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Table IV. Effects of erv41 and erv46
Strain number
FY834
CBY356
CBY799
CBY797
CBY795
CBY823
CBY825
CBY894
CBY832
CBY841
CBY843
CBY845
CBY912
CBY910
CBY914
CBY943
CBY941
CBY945
CBY849
CBY851
CBY852
CBY853
CBY855
CBY857
CBY860
CBY862
CBY863
CBY923
CBY921
CBY924
CBY932
CBY933
CBY930
CBY917
CBY916
CBY919
CBY964
CBY949
CBY970
CBY968

Genotype

Phenotype*

wild type
erv14⌬
erv46⌬
erv41⌬
erv41⌬ erv46⌬
erv14⌬ erv46⌬
erv14⌬ erv41⌬
erv14⌬ erv41⌬ erv46⌬
erv41⌬ erv46⌬ emp24⌬
erv41⌬ ypt1-3
erv46⌬ ypt1-3
erv41⌬ erv46⌬ ypt1-3
erv41⌬ uso1-1
erv46⌬ uso1-1
erv41⌬ erv46⌬ uso1-1
erv41⌬ sec35-1
erv46⌬ sec35-1
erv41⌬ erv46⌬ sec35-1
erv41⌬ sec21-1
erv46⌬ sec21-1
erv41⌬ erv46⌬ sec21-1
erv41⌬ sed5-1
erv46⌬ sed5-1
erv41⌬ erv46⌬ sed5-1
erv41⌬ sec12-1
erv46⌬ sec12-1
erv41⌬ erv46⌬ sec12-1
erv41⌬ sec16-2
erv46⌬ sec16-2
erv41⌬ erv46⌬ sec16-2
erv41⌬ sec13-1
erv46⌬ sec13-1
erv41⌬ erv46⌬ sec13-1
erv41⌬ sec23-1
erv46⌬ sec23-1
erv41⌬ erv46 sec23-1
erv14⌬ rer1⌬
erv41⌬ rer1⌬
erv29⌬ erv14⌬
erv29⌬ erv41⌬

—
Delayed germination, slightly slower growth, cold sensitive
Cold sensitive
Delayed germination, cold sensitive
No effect
Slow germination, slow growth, cold sensitive
Very slow germination, slow growth, cold sensitive
Extremely slow germination, slow growth, cold sensitive
No effect
Significant decrease in temperature sensitivity
Slight increase in temperature sensitivity
Significant decrease in temperature sensitivity
No effect
No effect
No effect
No effect
No effect
No effect
No effect
No effect
No effect
No effect
No effect
No effect
No effect
No effect
No effect
No effect
No effect
No effect
No effect
No effect
No effect
No effect
No effect
No effect
No effect
No effect
No effect
No effect

*Conditions tested: YPD at 16⬚C, 25⬚C, 30⬚C, 36⬚C, and 38⬚C.

To further investigate a possible defect in ER to Golgi
transport, we used an in vitro transport assay that permitted us to differentiate between the budding, tethering, and
fusion stages (Barlowe, 1997; Cao et al., 1998). We have

found this assay to be a more sensitive method to measure
transport between the ER and Golgi. In some instances,
mutant strains that display normal transport kinetics in
pulse–chase experiments show defects in distinct stages of

Figure 7. Pulse–chase analysis of CPY maturation in wild-type and erv14⌬ erv46⌬ deletion strains. Wild-type (wt, FY833), erv46⌬
(46⌬, CBY798), erv14⌬ (14⌬, CBY358), and erv14⌬ erv46⌬ (14⌬ 46⌬, CBY822) strains were pulsed for 7 min with 35S-labeled cysteine
and methionine and then chased for 10 or 20 min. Labeled CPY was immunoprecipitated from cell extracts, resolved on a 10% polyacrylamide gel, and visualized by autoradiography.
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cell-free transport (Conchon et al., 1999). Washed semiintact cells containing 35S-labeled gp-␣-F bud 35S-labeled gp␣-F–containing vesicles in the presence of COPII proteins.
Packaged 35S-labeled gp-␣-F in vesicles can be quantified
by precipitation with concanavalin A–Sepharose, allowing
us to assay budding efficiencies. The vesicle tethering
stage may be monitored as the decrease in diffusible
COPII vesicles upon addition of the tethering protein
Uso1p. Lastly, reconstituted transport to the Golgi complex can be measured after addition of COPII, Uso1p, and
LMA1 to semiintact cells by precipitation of Golgi-modified forms of 35S-labeled gp-␣-F with ␣1,6-mannose–specific antiserum. As seen in Fig. 8 A, the budding and tethering stages of transport were not impaired in mutant
strains compared with a wild-type strain. However, there
was a modest but significant decrease in transport to the
Golgi complex in the erv41⌬, erv46⌬, and the double
erv41⌬ erv46⌬ membranes (Fig. 8 B). Notably, the effects
of the single deletions were neither additive nor cooperative when combined in the double mutant strain. Together, these results suggest that the transport defect occurred during the fusion stage of this assay. Also, we
examined transport efficiencies in the presence of a crude
cytosol to determine if the erv41⌬ erv46⌬ membranes required additional factors not provided by purified reconstitution proteins. As shown in Fig. 8 C, a similar transport
defect was observed for reactions using crude cytosol or
purified proteins to drive transport.

Association of Erv41p and Erv46p
Based on the colocalization of Erv41p and Erv46p, the
similarity in phenotypes displayed by erv41⌬ and erv46⌬
in our genetic experiments and the nonadditive effects of
the erv41⌬ and erv46⌬ mutations on ER–Golgi transport
assays, we suspected that these proteins act together and
possibly form a complex. Therefore, we investigated
whether the expression of Erv41p and Erv46p is interdependent by immunoblotting cells containing the erv41⌬,
erv46⌬, and erv41⌬ erv46⌬ alleles with antisera against
Erv41p and Erv46p. The erv46⌬ strain did not express a
detectable level of Erv41p, and the erv41⌬ strain exhibited
a reduced expression of Erv46p compared with the wild
type (Fig. 9). Consistent with these findings, we observed
that Erv46p could be expressed at higher levels from a 2
plasmid than Erv41p (Fig. 3). A strain carrying both
ERV41 and ERV46 on 2 plasmids did not express either
of them at levels higher than a strain just overexpressing
Erv46p (not shown). Also, the expression level of endogenous Erv41p could be elevated (approximately twofold) if
Erv46p was overproduced under control of the GAL1 promoter (compare the total [T] lanes in Fig. 10). These re-

Figure 8. Influences of erv41⌬ and erv46⌬ mutations on ER–
Golgi transport. (A) Vesicle budding and tethering in washed
semiintact cells prepared from wild-type (wt, FY834), erv41⌬
(41⌬, CBY797), erv46⌬ (46⌬, CBY799), and erv41⌬ erv46⌬ (41⌬
46⌬, CBY795) strains. The levels of diffusible vesicles in reactions
without reconstitution proteins (NA), with COPII proteins
(⫹COPII), and with COPII proteins plus the tethering factor

Uso1p (⫹COPII/Uso1p) are indicated. (B) Overall transport of
35
S-labeled gp-␣-F to the Golgi complex in the same strains. Semiintact cells were incubated alone (NA) or with the reconstitution
proteins COPII, Uso1p, and LMA1 (⫹Recon). (C) Overall transport of 35S-labeled gp-␣-F factor to the Golgi complex in wildtype (wt, FY834) and erv41⌬ erv46⌬ (41⌬ 46⌬, CBY795) strains.
Semiintact cells were incubated alone (NA), with cytosol, or with
the reconstitution proteins COPII, Uso1p, and LMA1 (⫹Recon).
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Figure 9. Erv41p and Erv46p
depend on each other for
their expression. wt, wild-type
strain FY834; 46⌬, erv46⌬ deletion strain CBY799; 41⌬,
erv41⌬
deletion
strain
CBY797; and 41⌬ 46⌬,
erv41⌬ erv46⌬ double deletion strain CBY795. Semiintact cells were resolved on a
12.5% polyacrylamide gel
and immunoblotted with
polyclonal anti-Erv41p and
anti-Erv46p antisera. Kar2p is
shown as a loading control.

Using a reconstituted budding assay combined with mass
spectrometry, we have identified four known transmembrane protein constituents of COPII-coated vesicles
(Erv14p, Emp24p, Erv25p, and Bet1p), and have localized
six other characterized proteins (Yip3p, Rer1p, Erp1p,
Erp2p, Yif1p, and Emp47p) and three additional novel
proteins (Erv29p, Erv41p, and Erv46p) to these carrier
vesicles. We went on to characterize Erv41p and Erv46p,
two related proteins that are conserved across species.
Both are integral transmembrane proteins and are predicted to have large lumenal domains with shorter
COOH- and NH2-terminal cytoplasmic segments. Localization studies show that both proteins reside in the Golgi
and ER at steady state. erv41⌬ and erv46⌬ strains are
cold-sensitive, and these deletions exacerbate the erv14⌬

phenotype. The erv41⌬ and erv46⌬ mutations also influence the thermosensitivity of a ypt1-3 strain. Strains carrying the erv41⌬ and erv46⌬ null alleles show normal vesicle
budding and tethering but a reduced overall transport efficiency between the ER and Golgi, suggesting a defect
downstream of the tethering stage. Expression of Erv41p
and Erv46p is interdependent, and both proteins could be
coimmunoprecipitated, indicating that these proteins are
physically associated.
In discussing potential functions for Erv41p and Erv46p,
it may be informative to consider other characterized vesicle proteins. We have now identified four p24 proteins on
isolated ER-derived vesicles. Yeast has eight members of
this family, Erv25p (Belden and Barlowe, 1996), Emp24p
(Schimmöller et al., 1995), and Erp1p to Erp6p (Marzioch
et al., 1999). These abundant, conserved, integral type I
transmembrane proteins have been found in COPI and
COPII vesicles and have been shown to shuttle between
the ER and Golgi. Their cytosolic tails have a high affinity
for coat proteins and have been proposed to act as a scaffold during the formation of the protein coat (Bremser et
al., 1999), as transport receptors for secretory cargo
(Schimmöller et al., 1995) or as negative regulators of vesicle budding that influence cargo sorting (Elrod-Erickson
and Kaiser, 1996). However, a strain that lacks all eight
p24 proteins is viable and did not show defects in overall COPI- or COPII-mediated transport (Kaiser, 2000;
Springer et al., 2000), indicating that they do not perform
an essential role in transport through the early secretory
pathway in yeast. The phenotypes associated with p24 deletion strains are consistent with a role in protein and/or
lipid sorting during vesicle budding either by association
with cargo or through formation of specialized sorting regions or membrane compartments. The expression levels
of the Erv25p, Emp24p, Erp1p, and Erp2p are interdependent, these proteins are found associated in a heterooligomeric complex, and strains lacking any one subunit of this
complex exhibit similar phenotypes (Marzioch et al.,
1999). Our detection of the Erp1p and Erp2p proteins on
COPII vesicles is consistent with these observations, and
we are testing the possibility that this heterooligomeric
p24 complex is packaged en bloc during vesicle formation.
Yip3p and Yif1p, two previously identified proteins,
were also encountered on ER-derived vesicles. The Yip
proteins were initially discovered as Ypt1p interacting
proteins (Yang et al., 1998) and Yif1p as a Yip1p interact-
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sults indicate that the expression of Erv41p is highly dependent on the presence of Erv46p, and to a lesser extent
Erv46p expression depends on the presence of Erv41p.
One interpretation of these results is that Erv41p and
Erv46p are associated in a multisubunit protein complex,
and when one of the members of this complex is absent,
the other subunit(s) is destabilized.
To determine if Erv41p and Erv46p are physically associated, we performed a native immunoprecipitation experiment from detergent-solubilized membranes. Microsomes
from a wild-type strain and from a strain expressing 3HAErv46p were solubilized with Triton X-100, and tagged
Erv46p was precipitated by the addition of anti-HA antibodies. As seen in Fig. 10, Erv41p coprecipitated with 3HAErv46p in the tagged strain, whereas no Erv41p was precipitated from the untagged wild-type microsomes. As controls,
neither Sec23p nor Erv25p were precipitated, indicating
that the association of 3HA-Erv46p with Erv41p was specific. In other experiments, we found that HA-tagged
Erv41p could be coimmunoprecipitated with Erv46p when
Erv46p specific polyclonal antibodies were used (not
shown). Finally, we observed that endogenous Erv46p was
not detected in complexes that were isolated with 3HAErv46p (Fig. 10; Otte, S., unpublished observation). Collectively, the expression studies and immunoprecipitation
results indicate that Erv41p and Erv46p are physically associated in a heteromeric complex and that these complexes
probably contain single Erv46p and Erv41p subunits.

Discussion

Figure 10. Erv41p is coimmunoprecipitated with HA-tagged
Erv46p. Microsomes were prepared from FY833 (⫺ HAErv46p) and CBY767 (⫹ HAErv46p) cells grown in YP with
2% galactose and 0.2% glucose
and solubilized with buffer containing 2% Triton X-100 (T).
The soluble extracts (S) were incubated in absence (⫺ anti-HA
ab) or presence (⫹ anti-HA ab)
of the monoclonal anti-HA antibody. Precipitates were resolved
on a 12.5% polyacrylamide gel
and immunoblotted for Sec23p,
Erv46p, Erv41p, and Erv25p.

ing factor (Andrulis et al., 1998). Ypt1p is a small GTPase
required for vesicle transport through the early secretory
pathway (Rexach and Schekman, 1991; Segev et al., 1988)
and therefore the Yip and Yif proteins are thought to operate in conjunction with GTPases to catalyze vesicle fusion. Yip1p and Yif1p are integral membrane proteins that
localize predominantly to Golgi membranes and possess
hydrophilic NH2-terminal domains facing the cytosol. Recently, a Yip1p–Yif1p complex has been proposed to function as a receptor in recruiting GTPases to specific membranes, perhaps acting as a GDI displacement factor
(Yang et al., 1998; Matern et al., 2000). We find the
Yip1p–Yif1p complex is efficiently packaged into COPII
vesicles, suggesting that these proteins actively cycle between the ER and Golgi compartments. It seems possible
that the Yip1–Yif1p complex on vesicles could act directly
to target vesicles to Ypt1p on the surface of Golgi membranes or Yip1p–Yif1p could perform a more general role
in recruiting GTPases to several distinct intracellular
membranes. Further studies will be needed to distinguish
between these possibilities.
Rer1p is required for the ER localization of type II
transmembrane proteins (e.g. Sec12p) and has been proposed to couple retrieved proteins to the COPI coat during
retrograde Golgi to ER transport (Sato et al., 1995; Boehm
et al., 1997; Sato et al., 1997). We have found that Rer1p is
included in COPII vesicles with a high efficiency, suggesting this protein actively cycles between the ER and Golgi
compartments. Our observation seems consistent with the
proposed function of Rer1p in retrieval of ER residents
from post-ER compartments. However, it remains to be
determined if the COPII-dependent forward transport of
Rer1p reflects recycling necessary to perform its function
in retrieval of ER residents or whether this protein performs additional roles in anterograde transport.
We had expected that the abundant Erv proteins would

represent transport machinery involved in vesicle formation, cargo selection, and membrane fusion (Belden and
Barlowe, 1996). To a large extent, our current study bears
this out. However, we also found that the outer-chain
mannosyltransferase (Och1p) was packaged into COPII
vesicles as has been previously reported (Bednarek et al.,
1995). Och1p was not detected in our mass spectral analysis, but antibodies against this protein were generated to
allow for a comparison of packaging efficiencies with
other Erv proteins. We find that Och1p is packaged into
COPII vesicles, albeit at a lower efficiency than most other
Erv proteins (Fig. 2), and is localized predominantly to
Golgi membranes (Fig. 5). The packaged Och1p could
represent newly synthesized protein in transit to the Golgi
or may belong to a class of Golgi localized proteins that
cycle between the ER and Golgi compartments at a significant rate as has been observed for mammalian galactosyltransferase (Zaal et al., 1999). It is interesting to note that
other Golgi localized proteins such as Ypt1p and GDPase
were not efficiently packaged into COPII vesicles (Cao
and Barlowe, 2000). Furthermore, in vivo studies indicate
that some Golgi-localized proteins cycle rapidly through
the ER, whereas others do not (Wooding and Pelham,
1998; Barrowman et al., 2000). It remains to be determined if cycling rates necessarily reflect an important
functional property. Regardless, the fact that some proteins typically thought to be Golgi residents are found in
COPII vesicles suggests that uncharacterized Erv proteins
could potentially belong to this group.
Erv41p and Erv46p are predicted to have large lumenal
domains and short NH2- and COOH-terminal cytosolic
tails that potentially interact with the COPII and/or COPI
coats. Based on these and other considerations discussed
above, we can envisage a few possible roles for the
Erv41p–Erv46p complex that are consistent with our experimental observations. First, this complex could perform
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a role similar to the p24 complex in sorting during vesicle
formation. The complex could fulfill this role through direct interaction with cargo molecules or by establishing
domains on the surface of budding membranes. In some
respects, the heteromeric arrangement, the membrane topology, and the nonessential phenotypes exhibited by the
Erv41p–Erv46p complex are reminiscent of the p24 deletion strains. We have not detected any specific secretory
cargo that accumulates in the erv41⌬ and/or erv46⌬ deletion strains, however, we currently have a very limited capability of monitoring individual secretory cargo. If the
Erv41p–Erv46p complex is required for the efficient transport of a small subset of nonessential cargo proteins, we
may not easily detect an accumulation. Second, the
Erv41p–Erv46p complex could operate in the retention
and/or retrieval of transport machinery to the early secretory pathway. For example, as Rer1p acts in the retrieval
of Sec12p and other ER residents, the Erv41p–Erv46p
complex could operate in localizing proteins to Golgi
membranes. In keeping with this idea, the erv41⌬ erv46⌬
strain displayed a modest defect in the fusion stage of in
vitro transport between the ER and Golgi, suggesting the
Erv41p–Erv46p complex could interact with or serve to
correctly localize the membrane fusion machinery (e.g.,
SNAREs and SNARE regulatory proteins). Third, the
Erv41p–Erv46p complex may not act in movement or localization of proteins, but could be involved in lipid transport. A majority of cellular phospholipid, glycolipid, and
sterol synthesis occurs in the ER (for review see Daum et
al., 1998), and it seems probable that specific proteins act
to sort and transport these species to their proper location.
Although nonsecretory routes exist for lipid transport,
much of this lipid transport occurs through the classical
secretory pathway and presumably through COPII vesicles. Therefore, the observed in vitro defect during the
vesicle fusion stage could be caused by a suboptimal lipid
composition of vesicle or acceptor membrane bilayers,
leading to a reduction in membrane fusion efficiency. Finally, the Erv41p–Erv46p complex could perform a role in
the posttranslational maturation of secretory proteins such
as protein folding or glycosylation in the early secretory
pathway. If this last possibility were the case, we again
would speculate that the effect is on a subset of secretory
cargo because we do not detect any general defects in folding, no extracellular secretion of kar2p (Otte, S., unpublished observation), and no obvious alterations in N- or
O-linked oligosaccharide modifications.
Several recent reports suggest a role for COPII-dependent transport in regulation of cellular homeostasis (Niwa
et al., 1999; Nohturfft et al., 2000; Travers et al., 2000). Although the underlying mechanisms of these regulatory
pathways remain to be elucidated, our investigation of Erv
proteins may shed light on these questions. Notably, several of the proteins we have identified on COPII vesicles,
including the novel proteins Erv29p, Erv41p, and Erv46p,
are induced upon activation of the unfolded protein response pathway (Travers et al., 2000). With respect to the
Erv41p–Erv46p complex, it will be important to determine
binding partners that potentially include additional members of the heteromeric Erv41p–Erv46p complex, vesicle
coat proteins, and/or specific cargo molecules. We will
combine these biochemical approaches with cell-free
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transport assays and molecular genetic analyses of Erv41p–
Erv46p to elucidate their function.
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